Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Zimmer Holdings (NY: ZBH )

107.12 +1.31 (+1.24%)
Official Closing Price Updated: 7:00 PM EST, Dec 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zimmer Holdings

< Previous 1 2 3 4 5 6 7 Next >
Benzinga's Top Ratings Upgrades, Downgrades For November 23, 2021
Upgrades Keefe, Bruyette & Woods upgraded the previous rating for CBRE Group Inc (NYSE: 
Via Benzinga
Analyzing Zimmer Biomet Holdings's Unusual Options Activity
On Tuesday, shares of Zimmer Biomet Holdings (NYSE:ZBH) saw ... 
Via Benzinga
Recap: Zimmer Biomet Q2 Earnings
Shares of Zimmer Biomet Holdings (NYSE:ZBH) remained unaffected after the company reported Q2 results. Quarterly Results Earnings per share rose 3700.00% over the past year... 
Via Benzinga
Recap: Zimmer Biomet Q1 Earnings
Shares of Zimmer Biomet Holdings (NYSE:ZBH) moved higher by 0.0% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased... 
Via Benzinga
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name... 
Via Benzinga
Exposures Product Safety
10 Biggest Price Target Changes For Friday
Wedbush raised Uber Technologies, Inc. (NYSE:UBER)... 
Via Benzinga
Zimmer Biomet Holdings Inc (ZBH) Q3 2021 Earnings Call Transcript
ZBH earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Zimmer Biomet Shares Hit After Lowering Annual Guidance
Zimmer Biomet Holdings Inc's (NYSE: ZBH) Q3 sales decreased marginally by 0.3% Y/Y to $1.92 billion (down 0.8% on a constant currency basis), missing the... 
Via Benzinga
Price Over Earnings Overview: Zimmer Biomet Holdings
Looking into the current session, Zimmer Biomet Holdings Inc. (NYSE:ZBH) is trading at $145.73, after a 0.1% decrease. Over the past month, the stock fell by 0.64%,... 
Via Benzinga
Software Error Prompts Zimmer Biomet To Recall Rosa One Robotic Neurosurgery Platform
Zimmer Biomet Holdings Inc (NYSE: ZBH) is facing a Class I recall of its Rosa One Brain platform. Devices ranging from biopsy needles to endoscopes to deep brain... 
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &... 
Via Benzinga
Exposures COVID-19
Zimmer Biomet Scores FDA De Novo Nod For Smart Knee Implant
Zimmer Biomet Holdings Inc (NYSE: ZBH) and Canary Medical have announced that the FDA granted de novo classification for Persona IQ. The de novo grant... 
Via Benzinga
Exposures Product Safety
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc... 
Via Benzinga
FDA Approves Zimmer Biomet's Rosa Hip Personalized Robotic System
Zimmer Biomet Holdings Inc (NYSE: ZBH) has received FDA 510(k) clearance for its Rosa Hip system for robotically-assisted surgery. The system is designed for... 
Via Benzinga
Exposures Product Safety
Zimmer Biomet Holdings Inc (ZBH) Q2 2021 Earnings Call Transcript
ZBH earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Zimmer Biomet Stock Falls After Lowering Bottom End Of FY21 Outlook; Q2 Earnings Beat
Zimmer Biomet Holdings Inc (NYSE: ZBH) posted Q2 adjusted EPS of $1.90, ahead of the consensus of $1.87 and higher than $0.05 posted a year ago. It reported a profit of... 
Via Benzinga
A Look Into Zimmer Biomet's Price Over Earnings
Looking into the current session, Zimmer Biomet Holdings Inc. (NYSE:ZBH) is trading at $162.42, after a 0.20% drop. Over the past month, the stock decreased by 0.68... 
Via Benzinga
This Part of the Reopening Trade Is Just Getting Started
As hospitals address the major backlog of pandemic-postponed elective surgeries, medical device makers -- and their stock prices -- could benefit. 
Via The Motley Fool
Exposures COVID-19
Earnings Scheduled For August 3, 2021
Companies Reporting Before The Bell • Myriad Genetics (NASDAQ:MYGN) is likely to report earnings for its fourth quarter. • Stellantis (NYSE:STLA) is expected to... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2021
Upgrades For Appian Corp (NASDAQ:APPN), Macquarie upgraded the previous rating of Underperform to Neutral. For the first quarter, Appian had an EPS of $0.06, compared to... 
Via Benzinga
1 More Excellent Reason to Love This Leading Healthcare Company
As elective surgery candidates return to operating rooms, revenue will ramp up. 
Via The Motley Fool
Exposures COVID-19
Zimmer Biomet Holdings Inc (ZBH) Q1 2021 Earnings Call Transcript
ZBH earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Zimmer Biomet Stock Dips Despite Q1 Earnings Beat, Better-Than-Expected Guidance
Zimmer Biomet Holdings Inc (NYSE: ZBH) shares took a hit today despite first-quarter results beating the consensus. Adjusted diluted EPS of $1.71, grew 0.6% Y... 
Via Benzinga
Topics Earnings
Exposures Financial
The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 3) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
Earnings Scheduled For May 4, 2021
Companies Reporting Before The Bell • Lancaster Colony (NASDAQ:LANC) is likely to report quarterly earnings at $1.24 per share on revenue of $340.02 million. •... 
Via Benzinga
Zimmer Biomet Holdings Earnings Preview
Zimmer Biomet Holdings (NYSE:ZBH) announces its next round of earnings this Tuesday, May 04. Here is Benzinga's everything-that-matters guide for this Tuesday's Q1 earnings... 
Via Benzinga
The Daily Biotech Pulse: Hyperphosphatemia Drug Regulatory Review Extended, Phathom Pharma Data Readout, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29) AtriCure, Inc. (NASDAQ:... 
Via Benzinga
Stocks That Hit 52-Week Highs On Wednesday
Before 10 a.m. ET on Wednesday, 140 companies hit new 52-week highs. Noteworthy Highlights: The largest company by market cap to set a new 52-week high was... 
Via Benzinga
The Daily Biotech Pulse: KemPharm Receives $10M Milestone Payment, Zymergen, Neuropace Debut On Nasdaq, Renalytix Wins US Government Contract, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 21) Alexion Pharmaceuticals,... 
Via Benzinga
The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche's Diagnostics Business Comes to Rescue
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 20) Alexion Pharmaceuticals,... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.